CA
NZ
UK
AU
IND
US
Operating income was $266 million, against $102 million.Net Incomewas $78 million, compared with a net loss of $10 million, and net income attributable to common stockholders was $66 million, against a loss of $23 million.Diluted Earnings per Sharewere $0.66, compared with a loss of …
Net income was $14.7 million, against $23.8 million, andDiluted Earnings per Sharewere $0.75, against $1.17. Adjusted EPS was $0.77, compared with $1.21 in the prior-year quarter. Management said a higher tax rate reduced adjusted EPS by $0.07 compared with last year.
Net income was $1.0 million, or $0.03 per diluted share, against $0.2 million, or $0.01. Pre-tax income was $2.6 million, against $1.5 million. Total operating expenses were $209.3 million, against $196.3 million, with cost of services as a percentage of revenue up 160 basis …
The company attributed the increase mainly to higher international COVIDVaccinesales, supported by deliveries under long-term strategic government partnerships. Revenue was $780 million in the United States and $533 million in international markets.
Net loss was $31.137 million, against $8.798 million a year earlier. Diluted loss per share attributable to the company's stockholders was $1.29, compared with $0.37.
Net loss was $41.746 million, or $0.22 per Class A share, compared with a net loss of $29.722 million, or $0.20 per share, a year earlier. Weighted average Class A shares were 188.6 million, against 150.4 million.
Operating loss was $3.059 billion, against $1.165 billion. Net loss was $2.858 billion, compared with $1.190 billion, and net loss attributable to Optimum Communications stockholders was $2.884 billion, or $10.24 per share, against $1.194 billion, or $2.55 per share.
Adjusted EBITDA was $847 million, against $806 million, and Adjusted EBITDA attributable to PAA was $711 million, against $669 million. Implied distributableCash Flowper common unit was $0.67, against $0.61. Adjusted free cash flow was $458 million, against $303 million.
Total revenues were $545.9 million, against $488.9 million. Diluted loss per share on aGAAPbasis was $1.08, against earnings of $0.19 in the third quarter of 2025.
Total RevPAR increased 10.5% to $394.97. Excluding Andaz Miami Beach, Hotel Adjusted EBITDAreMarginincreased 50 basis points to 26.7%. Adjusted FFO attributable to common stockholders was $37.2 million, against $31.7 million.
Please wait processing your request...